A future for CD3 antibodies in immunotherapy of type 1 diabetes
Crossref DOI link: https://doi.org/10.1007/s00125-018-4808-7
Published Online: 2019-01-05
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chatenoud, Lucienne http://orcid.org/0000-0002-1328-2786
Text and Data Mining valid from 2019-01-05
Article History
Received: 5 December 2018
Accepted: 12 December 2018
First Online: 5 January 2019
Duality of interest
: The author has received an honorarium from Provention Bio.